The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 2 – Asrar Qureshi’s Blog Post #1292

This blog post by Asrar Qureshi examines the exit of multinational pharmaceutical companies from Pakistan, analyzing its historical context and impacts on the healthcare system. While local firms maintain medicine availability, concerns arise regarding innovation and clinical research. The challenge remains to balance local manufacturing capabilities with the need for multinational investment and research.
Share
Scientist pipetting liquid into a tray in a laboratory setting with lab equipment and computer displaying graphs
View Post

Why Multinational Pharmaceutical Companies Are Leaving Pakistan – Asrar Qureshi’s Blog Post #1291

Asrar Qureshi’s blog post discusses the exit of multinational pharmaceutical companies from the Pakistani market, highlighting historical contributions, major exits, and the challenges faced by these firms, such as drug price controls and currency depreciation. Despite local companies acquiring many brands, concerns about access to innovative therapies and a decline in research presence persist.
Share
View Post

Pharma Marketing Over Decades– Asrar Qureshi’s Blog Post #1079

Asrar Qureshi’s blog discusses the transformation of pharmaceutical marketing, highlighting a shift from sales-driven approaches to patient-centric strategies. While global trends favor digital engagement and direct-to-consumer marketing, Pakistan remains reliant on traditional methods. Greater compliance and ethical engagement are necessary to modernize the industry and meet evolving patient expectations.
Share